Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of School-based Malaria Treatment on Attendance in Malawi
NCT02213211Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Apr 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of artemether + lumefantrine in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: School attendance at 1 year. Started Apr 2014; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02213211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213211.